生命科学资讯

UK lowers new medicine rebate scheme to 14.5% for 2026

D3 Bio raises $108M to take next-gen KRAS G12C drug into Phase 3

BlossomHill gets another $84M for macrocyclic approach to EGFR

Cytiva and Fida Biosystems Combine Technologies to Expand Protein Analysis - Genetic Engineering and Biotechnology News

Thermo Fisher Scientific on the value of an integrated approach to drug development - Pharmaphorum

Cytiva and Fida Biosystems collaborate to improve molecular insight for faster drug discovery - BioSpectrum Asia

Q3 Earnings Outperformers: Agilent (NYSE:A) And The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance

Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina

Is It Time To Reassess Thermo Fisher Scientific After Its Recent Share Price Pullback? - simplywall.st

Thermo Fisher Expands BioProcessing in Asia - Powder & Bulk Solids

Is Thermo Fisher Still Attractively Priced After Recent Share Price Dip In 2025? - Yahoo Finance

Goldman Sachs Initiates Coverage of Agilent Technologies (A) with Buy Recommendation - Nasdaq

Rainbows, pickleball and puppies: Inside the ‘enduring activism’ and ‘cautious optimism’ at ASH 2025

Evidence of centromeric histone 3 chaperone involved in DNA damage repair pathway in budding yeast

The impact of different antimicrobial exposures on the gut microbiome in the ARMORD observational study

Addressing cultural and knowledge barriers to enable preclinical sex inclusive research

Dock-and-lock binding of SxIP ligands is required for stable and selective EB1 interactions

Longitudinal tracking of neuronal activity from the same cells in the developing brain using Track2p

FDA is taking another look at safety of approved RSV antibodies

Eli Lilly earmarks $6B for GLP-1 pill factory in Alabama